Summary
- Current Price
- As of today, CANF price is $1.47, down -2.69% on
- Current Price All-Time High
- CANF price is currently -99.99% below its historical high of $28,380.00 set on
- Market Cap
- CANF current market cap is $4M, down -85.11% year-over-year
- Revenue
- CANF current annual revenue is $408.20K, down -39.72% year-over-year
- Next Earnings
- As of today, the next earnings release for CANF has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Can-Fite BioPharma Ltd. |
| Ticker | NYSEAmerican: CANF |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | canfite.com |
| Employees | 5 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.47 | ||
| Price, 1D Change | -2.69% | |
| $4M | ||
| - | ||
| - | ||
| 0.66 | ||
| $408.20K | ||
| Revenue, 1Y Change | -39.72% | |
| -$12.03 | ||
| EPS, 1Y Change | +44.85% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$12.03 | ||
| EPS Estimate | -$2.04 | N/A |
| EPS Est. Change | +83.05% | N/A |
| $408.20K | ||
| Revenue Estimate | $404.00K | N/A |
| Revenue Est. Change | -1.03% | N/A |
| $1.47 | ||
| Price Target | $8.00 | - |
| Price Tgt. Change | +444.44% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$21.82 | - | |
| -$10.40 | -$12.03 | -15.72% | |
| -$2.04 | N/A | +83.05% | |
| -$0.91 | N/A | +92.44% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $500.00K | $677.20K | +35.44% | |
| $202.00K | $408.20K | +102.08% | |
| $404.00K | N/A | -1.03% | |
| $404.00K | N/A | -1.03% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -77.74% | ||
| -96.29% | ||
| -85.11% | ||
| -97.24% | ||
| -39.72% | ||
| -49.60% | ||
| +44.85% | ||
| -221.70% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.47 | ||
| $3.03 | ||
| $1.90 | ||
| $4.11 | ||
| $1.93 | ||
| -$0.13 | ||
| 0.66 | ||
| $0.10 | ||
| 32.88 | ||
| 75.44% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $408.20K | ||
| -$12.03 | ||
| $384.00K | ||
| 94.07% | ||
| -$10.03M | ||
| -2,456.86% | ||
| -$9.91M | ||
| -2,426.75% | ||
| -$10.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 3.46 | ||
| 3.46 | ||
| - | ||
| - | ||
| -27.83 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 0.92 | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $5.59M | ||
| $8.54M | ||
| $9.51M | ||
| $9.44M | ||
| $3.92M | ||
| $2.73M | ||
| $71.00K | ||
| $56.00K | ||
| $1.16M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $10.31M | ||
| $10.41M | ||
| $24.20K | ||
| $0.00 | ||
| $24.20K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$9.02M | ||
| -$2,000.00 | ||
| $9.72M | ||
| $2,000.00 | ||
| -$9.02M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CANF
FAQ
- What is the ticker symbol for Can-Fite BioPharma Ltd.?
- The ticker symbol for Can-Fite BioPharma Ltd. is NYSEAmerican:CANF
- Does Can-Fite BioPharma Ltd. pay dividends?
- No, Can-Fite BioPharma Ltd. does not pay dividends
- What sector is Can-Fite BioPharma Ltd. in?
- Can-Fite BioPharma Ltd. is in the Healthcare sector
- What industry is Can-Fite BioPharma Ltd. in?
- Can-Fite BioPharma Ltd. is in the Biotechnology industry
- What country is Can-Fite BioPharma Ltd. based in?
- Can-Fite BioPharma Ltd. is headquartered in Israel
- When did Can-Fite BioPharma Ltd. go public?
- Can-Fite BioPharma Ltd. initial public offering (IPO) was on November 6, 2012
- Is Can-Fite BioPharma Ltd. in the S&P 500?
- No, Can-Fite BioPharma Ltd. is not included in the S&P 500 index
- Is Can-Fite BioPharma Ltd. in the NASDAQ 100?
- No, Can-Fite BioPharma Ltd. is not included in the NASDAQ 100 index
- Is Can-Fite BioPharma Ltd. in the Dow Jones?
- No, Can-Fite BioPharma Ltd. is not included in the Dow Jones index
- When was Can-Fite BioPharma Ltd. last earnings report?
- Can-Fite BioPharma Ltd.'s most recent earnings report was on August 31, 2018
- When does Can-Fite BioPharma Ltd. report earnings?
- The date for Can-Fite BioPharma Ltd.'s next earnings report has not been announced yet
Data Sources & References
- CANF Official Website www.canfite.com
- CANF Profile on Yahoo Finance finance.yahoo.com/quote/CANF
- CANF Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/canf
